Pay by disease don't forget the embarrassment of "nameless" traditional Chinese Medicine

"In the new round of deepening medical reform, the state will take measures such as" pay by disease "to determine the varieties and pricing of basic drugs and medical insurance catalogue, which plays a positive role in reasonably controlling medical expenses and reducing the burden of the masses, and should be strongly supported." Xiao Wei, deputy to the National People's Congress and chairman of Jiangsu Kangyuan group, said, "but" payment by disease "may lead to the failure of reimbursement or affect the development of traditional Chinese medicine, which should not be ignored in the reform." The representative of Xiao Wei said that the disease name of Western medicine was basically used in the "payment by disease type" However, no matter the type of traditional Chinese medicine based medicine or the type of medical insurance, the title of Western medicine's disease name was missing under the functional indications in the manual of many Chinese patent medicines, because it could not be "put in the right place", it would inevitably lead to the situation that Chinese patent medicines could not be reimbursed by medical insurance, which would seriously restrict the development of Chinese medicine industry Exhibition The representative of Xiao Wei suggested that, in view of the lack of Western medicine's disease name expression in many Chinese patent medicines, the competent government departments should issue a unified disease syndrome comparison table of traditional Chinese medicine and Western medicine, so as to facilitate the implementation of "disease type" payment.